Cover Image
Market Research Report
Product code 
1083089

Global Gynecological Cancers Therapeutics Market 2022-2026

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Gynecological Cancers Therapeutics Market 2022-2026
Published: May 29, 2022
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Technavio has been monitoring the gynecological cancers therapeutics market and it is poised to grow by $ 14.22 bn during 2022-2026, accelerating at a CAGR of 14.67% during the forecast period. Our report on the gynecological cancers therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of gynecological cancers, a strong pipeline and new drug approvals, and a rising number of patient assistance programs.

The gynecological cancers therapeutics market analysis includes type segment and geographic landscape.

Technavio's gynecological cancers therapeutics market is segmented as below:

By Type

  • Uterine cancer
  • Ovarian cancer
  • Cervical cancer
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the emergence of novel therapies as one of the prime reasons driving the gynecological cancers therapeutics market growth during the next few years. Also, availability of advanced diagnostic modalities and rising awareness of gynecological cancers will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on gynecological cancers therapeutics market covers the following areas:

  • Gynecological cancers therapeutics market sizing
  • Gynecological cancers therapeutics market forecast
  • Gynecological cancers therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gynecological cancers therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Bristol Myers Squibb Co., Clovis Oncology Inc., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, ImmunoGen Inc., Johnson and Johnson, Karyopharm Therapeutics Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Siemens Healthcare GmbH, and Teva Pharmaceutical Industries Ltd.. Also, the gynecological cancers therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73551

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

  • 5.1 Market segments
  • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
  • 5.2 Comparison by Type
  • Exhibit 26: Chart on Comparison by Type
  • Exhibit 27: Data Table on Comparison by Type
  • 5.3 Uterine cancer - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Uterine cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Uterine cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Uterine cancer - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Uterine cancer - Year-over-year growth 2021-2026 (%)
  • 5.4 Ovarian cancer - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Ovarian cancer - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Ovarian cancer - Year-over-year growth 2021-2026 (%)
  • 5.5 Cervical cancer - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Cervical cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Cervical cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Cervical cancer - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Cervical cancer - Year-over-year growth 2021-2026 (%)
  • 5.6 Others - Market size and forecast 2021-2026
  • Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.7 Market opportunity by Type
  • Exhibit 44: Market opportunity by Type ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 48: Chart on Geographic comparison
  • Exhibit 49: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 China - Market size and forecast 2021-2026
  • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.9 Germany - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.10 Canada - Market size and forecast 2021-2026
  • Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.11 UK - Market size and forecast 2021-2026
  • Exhibit 82: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 83: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 84: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 85: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 89: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 90: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 91: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 92: Matrix on vendor position and classification
  • 10.3 AbbVie Inc.
  • Exhibit 93: AbbVie Inc. - Overview
  • Exhibit 94: AbbVie Inc. - Product / Service
  • Exhibit 95: AbbVie Inc. - Key offerings
  • 10.4 Amgen Inc.
  • Exhibit 96: Amgen Inc. - Overview
  • Exhibit 97: Amgen Inc. - Product / Service
  • Exhibit 98: Amgen Inc. - Key offerings
  • 10.5 AstraZeneca Plc
  • Exhibit 99: AstraZeneca Plc - Overview
  • Exhibit 100: AstraZeneca Plc - Product / Service
  • Exhibit 101: AstraZeneca Plc - Key news
  • Exhibit 102: AstraZeneca Plc - Key offerings
  • 10.6 Bristol Myers Squibb Co.
  • Exhibit 103: Bristol Myers Squibb Co. - Overview
  • Exhibit 104: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 105: Bristol Myers Squibb Co. - Key offerings
  • 10.7 Clovis Oncology Inc.
  • Exhibit 106: Clovis Oncology Inc. - Overview
  • Exhibit 107: Clovis Oncology Inc. - Business segments
  • Exhibit 108: Clovis Oncology Inc. - Key offerings
  • Exhibit 109: Clovis Oncology Inc. - Segment focus
  • 10.8 Daiichi Sankyo Co. Ltd.
  • Exhibit 110: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibit 111: Daiichi Sankyo Co. Ltd. - Business segments
  • Exhibit 112: Daiichi Sankyo Co. Ltd. - Key news
  • Exhibit 113: Daiichi Sankyo Co. Ltd. - Key offerings
  • Exhibit 114: Daiichi Sankyo Co. Ltd. - Segment focus
  • 10.9 Eli Lilly and Co.
  • Exhibit 115: Eli Lilly and Co. - Overview
  • Exhibit 116: Eli Lilly and Co. - Product / Service
  • Exhibit 117: Eli Lilly and Co. - Key offerings
  • 10.10 F. Hoffmann La Roche Ltd.
  • Exhibit 118: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 119: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 120: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 121: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 122: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.11 GlaxoSmithKline Plc
  • Exhibit 123: GlaxoSmithKline Plc - Overview
  • Exhibit 124: GlaxoSmithKline Plc - Business segments
  • Exhibit 125: GlaxoSmithKline Plc - Key news
  • Exhibit 126: GlaxoSmithKline Plc - Key offerings
  • Exhibit 127: GlaxoSmithKline Plc - Segment focus
  • 10.12 Merck and Co. Inc.
  • Exhibit 128: Merck and Co. Inc. - Overview
  • Exhibit 129: Merck and Co. Inc. - Business segments
  • Exhibit 130: Merck and Co. Inc. - Key news
  • Exhibit 131: Merck and Co. Inc. - Key offerings
  • Exhibit 132: Merck and Co. Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 133: Inclusions checklist
  • Exhibit 134: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 135: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 136: Research methodology
  • Exhibit 137: Validation techniques employed for market sizing
  • Exhibit 138: Information sources
  • 11.5 List of abbreviations
  • Exhibit 139: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Type - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Type - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Type
  • Exhibits27: Data Table on Comparison by Type
  • Exhibits28: Chart on Uterine cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Uterine cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Uterine cancer - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Uterine cancer - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Ovarian cancer - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Ovarian cancer - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Cervical cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Cervical cancer - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Cervical cancer - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Cervical cancer - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits44: Market opportunity by Type ($ million)
  • Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits48: Chart on Geographic comparison
  • Exhibits49: Data Table on Geographic comparison
  • Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits83: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits84: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits85: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits86: Market opportunity By Geographical Landscape ($ million)
  • Exhibits87: Impact of drivers and challenges in 2021 and 2026
  • Exhibits88: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits89: Overview on factors of disruption
  • Exhibits90: Impact of key risks on business
  • Exhibits91: Vendors covered
  • Exhibits92: Matrix on vendor position and classification
  • Exhibits93: AbbVie Inc. - Overview
  • Exhibits94: AbbVie Inc. - Product / Service
  • Exhibits95: AbbVie Inc. - Key offerings
  • Exhibits96: Amgen Inc. - Overview
  • Exhibits97: Amgen Inc. - Product / Service
  • Exhibits98: Amgen Inc. - Key offerings
  • Exhibits99: AstraZeneca Plc - Overview
  • Exhibits100: AstraZeneca Plc - Product / Service
  • Exhibits101: AstraZeneca Plc - Key news
  • Exhibits102: AstraZeneca Plc - Key offerings
  • Exhibits103: Bristol Myers Squibb Co. - Overview
  • Exhibits104: Bristol Myers Squibb Co. - Product / Service
  • Exhibits105: Bristol Myers Squibb Co. - Key offerings
  • Exhibits106: Clovis Oncology Inc. - Overview
  • Exhibits107: Clovis Oncology Inc. - Business segments
  • Exhibits108: Clovis Oncology Inc. - Key offerings
  • Exhibits109: Clovis Oncology Inc. - Segment focus
  • Exhibits110: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibits111: Daiichi Sankyo Co. Ltd. - Business segments
  • Exhibits112: Daiichi Sankyo Co. Ltd. - Key news
  • Exhibits113: Daiichi Sankyo Co. Ltd. - Key offerings
  • Exhibits114: Daiichi Sankyo Co. Ltd. - Segment focus
  • Exhibits115: Eli Lilly and Co. - Overview
  • Exhibits116: Eli Lilly and Co. - Product / Service
  • Exhibits117: Eli Lilly and Co. - Key offerings
  • Exhibits118: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits119: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits120: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits121: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits122: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits123: GlaxoSmithKline Plc - Overview
  • Exhibits124: GlaxoSmithKline Plc - Business segments
  • Exhibits125: GlaxoSmithKline Plc - Key news
  • Exhibits126: GlaxoSmithKline Plc - Key offerings
  • Exhibits127: GlaxoSmithKline Plc - Segment focus
  • Exhibits128: Merck and Co. Inc. - Overview
  • Exhibits129: Merck and Co. Inc. - Business segments
  • Exhibits130: Merck and Co. Inc. - Key news
  • Exhibits131: Merck and Co. Inc. - Key offerings
  • Exhibits132: Merck and Co. Inc. - Segment focus
  • Exhibits133: Inclusions checklist
  • Exhibits134: Exclusions checklist
  • Exhibits135: Currency conversion rates for US$
  • Exhibits136: Research methodology
  • Exhibits137: Validation techniques employed for market sizing
  • Exhibits138: Information sources
  • Exhibits139: List of abbreviations